DDW 2022: Immunomodulator Withdrawal Does Not Increase Risk of Loss of Response to Anti-TNFα Therapy for Inflammatory Bowel Disease
Withdrawal was associated with an increased risk of developing anti-drug antibodies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.